PCSK9 and familial hyperaldosteronism: However, it was previously found that PCSK9-i treatment ameliorated the pulse wave velocity (PWV), a biomarker of early cardiovascular injury, in a cohort of LDL off-target FH subjects (Scicali et al., 2021).